Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes

ABSTRACT: The SGLT2 inhibitor empagliflozin improved cardiovascular outcomes in patients with diabetes. As the cardiac mechanisms remain elusive, we investigated the long-term effects (up to 2 months) of empagliflozin on excitation-contraction (EC)-coupling in human cardiomyocytes derived from induc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Mol Med (Berl)
Asıl Yazarlar: Pabel, Steffen, Reetz, Florian, Dybkova, Nataliya, Shomroni, Orr, Salinas, Gabriela, Mustroph, Julian, Hammer, Karin P., Hasenfuss, Gerd, Hamdani, Nazha, Maier, Lars S., Streckfuss-Bömeke, Katrin, Sossalla, Samuel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7679329/
https://ncbi.nlm.nih.gov/pubmed/33034709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-020-01989-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller